4th Quarter - Report

CUBIST PHARMACEUTICALS, INC. for CUBIST PHARMACEUTICALS

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011 H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act (S. 1734), issues concerning technical clarifications; issues related to track and trace of pharmaceuticals; issues concerning Patient Centered Outcomes Research Institute grants. Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Technical changes to Food and Drug Administration Safety and Innovation Act (PL 112-144) Medical research Antibiotic resistance issues H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011 H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013 H.J. Res. 117, Continuing Appropriations Resolution

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1483 (112th), H.R. 2182 (112th), S. 3187 (112th), H.R. 5651 (112th), H.J.Res. 117 (112th), S. 3295 (112th), S. 1734 (112th)

Medicare/Medicaid MMM

H.R. 8, the American Taxpayers Relief Act of 2012 and issues concerning Medicare reimbursements for Part B and D 340B drug pricing program issues, including program expansion H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011 Medicare home infusion and reimbursement issues H. Con. Res. 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions) Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation) Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation) H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012 H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012 H.R. 6684, Spending Reduction Act of 2012

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Con.Res. 112 (112th), H.R. 5624 (112th), S. 1203 (112th), H.R. 8 (112th), H.R. 6684 (112th), H.R. 2195 (112th), H.R. 5194 (112th)

Budget/Appropriations BUD

H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions) H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013 H.J. Res. 117, Continuing Appropriations Resolution, 2013 Impact of sequestration on FDA user fees

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2375 (112th), H.R. 5973 (112th), H.J.Res. 117 (112th), H.Con.Res. 112 (112th)

Pharmacy PHA

Antibiotic resistance issues in the following bills Pay-for-delay proposals and generic issues H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011 Prescription Drug User Fee Act Reauthorization H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 2516, Food and Drug Administration Safety and Innovation Act S. 3187, Food and Drug Administration Safety and Innovation Act S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 6433, FDA User Fee Corrections Act of 2012 H.R. 8, American Taxpayer Relief Act of 2012

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5651 (112th), S. 2516 (112th), H.R. 8 (112th), S. 3187 (112th), S. 2289 (112th), S. 1734 (112th), H.R. 2182 (112th), S. 2292 (112th), H.R. 6433 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.